AzTrials
AzTrials

NewbornNCT05448508

The Effects of Manual and Automatic Lancets on Pain and Stress in Newborn Capillary Heel Blood Collection

A study testing Automatic lancet in people with Newborn and Pain, run by Ataturk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Heel blood sampling is a routine but painful procedure for newborns. A limited number of international studies have shown that automatic lancets are more effective with less pain and tissue damage than manual lancets. Read more about this study

Who is it for?
Ages 0 days to 1 dayHealthy volunteers can take part
Conditions the study is for
Newborn, Pain, Stress
What is being tested?
Automatic lancet
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2022to 1 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 days to 1 day
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Postnatal age zero day
  • Term newborn
  • No congenital anomalies
  • No advanced medical intervention at birth
  • Infants not receiving oxygen or respiratory support

Who cannot join

  • Legal guardian not giving consent to research

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • AtaturkU

    Yakutiye, Erzurum, 25000

Other trials in Turkey (Türkiye)

About this study

Heel blood sampling is a routine but painful procedure for newborns. A limited number of international studies have shown that automatic lancets are more effective with less pain and tissue damage than manual lancets.

In line with this information, this study was planned to investigate the effects of manual and automatic lancets on pain and stress in newborn capillary heel blood collection.

Conditions
Newborn, Pain, Stress
Being tested
Automatic lancet
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Automatic lancetDevice

    An automatic lancet, which can reach a depth of 2.4 mm-3 mm, was used for safe piercing in babies.

Study groups in NCT05448508
Study groupRoleWhat they receive
Automatic LancetExperimentalManual lancet, needle tips and automatic lancets are used in the heel blood collection process. It has been reported that there may be complications arising from health professionals in the use of manual lancet or needle tip. In this study, an automatic lancet penetrating 2.4 mm-3 mm depth was used for safe puncture in term newborns.
Receives: Device: Automatic lancet
ControlNo interventionNo intervention, routine maintenance performed

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The neo pain assessment scale

    The neo scale was developed (2014) to assess pain and stress in premature and mature neonates. The Neo is a five-item scale including facial expression, breathing pattern, tone of extremities, hand and foot activity, and level of activity. The lowest and the highest scores obtainable from the scale are 0 and 10, respectively. As the score increases, stress and pain increase.

    Measured: 12 week

  2. Crying time in second

    Measured: 12 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2022
  2. Study start1 Apr 2022
  3. Primary completion30 May 2022
  4. Study completion1 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05448508
Sponsor's protocol ID
TKP-2022-10664
Status last verified
Jul 2022
First submitted
2 Jul 2022
Last updated
7 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Kadiroglu T, Guven M, Yalcin R, Aslan A. The effects of manual and automatic lancet use on pain, stress, physiological parameters and crying duration during capillary heel blood collection in term neonates: a randomized controlled trial. BMC Nurs. 2025 Nov 18;24(1):1409. doi: 10.1186/s12912-025-04056-y.

    PubMed 41254729

Questions about this trial

What is this clinical trial studying?

A study testing Automatic lancet in people with Newborn and Pain, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The neo pain assessment scale (time frame: 12 week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05448508, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in